Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28225023)

Published in Sci Rep on February 22, 2017

Authors

Xingjiang Xiong1, Xiaochen Yang1, Lian Duan1, Wei Liu2, Yun Zhang3, Yongmei Liu3, Pengqian Wang4, Shengjie Li5, Xiaoke Li6

Author Affiliations

1: Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
2: Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
3: Department of Molecular Biology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
4: Department of Pharmacology, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
5: Department of Molecular Biology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
6: Bio-organic and Natural Products Laboratory, McLean Hospital, Harvard Medical School, Belmont, USA.

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78

Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76

A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet (2000) 9.78

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res (2003) 5.30

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA (2004) 3.68

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol (2012) 3.56

ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol (2011) 2.83

A public health approach to global management of hypertension. Lancet (2015) 2.75

Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol (2012) 2.57

Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertens Res (2013) 2.55

The heart in hypertension. N Engl J Med (1992) 2.53

Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Invest (2010) 2.12

Current situation and perspectives of clinical study in integrative medicine in china. Evid Based Complement Alternat Med (2012) 2.01

Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J (1993) 1.96

Mitogen-activated protein kinases in heart development and diseases. Circulation (2007) 1.84

Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension (1999) 1.71

Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ Res (2010) 1.56

Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis. Am J Hypertens (2010) 1.49

Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol (2001) 1.45

Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med (2002) 1.42

Hypertension: a global perspective. Circulation (2011) 1.31

Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med (2012) 1.29

NICE hypertension guideline 2011: evidence based evolution. BMJ (2012) 1.28

Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Ann N Y Acad Sci (2010) 1.23

Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens (2011) 1.23

Integrating traditional Chinese medicine into Western cardiovascular medicine: an evidence-based approach. Nat Rev Cardiol (2015) 1.16

Outcome measures of chinese herbal medicine for hypertension: an overview of systematic reviews. Evid Based Complement Alternat Med (2012) 1.14

Evidence-based chinese medicine for hypertension. Evid Based Complement Alternat Med (2013) 1.14

Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Exp Physiol (2010) 1.11

Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol (2006) 1.10

Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. Phytomedicine (2007) 1.08

Trends in the treatment of hypertension from the perspective of traditional chinese medicine. Evid Based Complement Alternat Med (2013) 1.07

Control strategy on hypertension in chinese medicine. Evid Based Complement Alternat Med (2011) 1.07

Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br J Gen Pract (2006) 1.03

Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens (2000) 1.03

Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens (2009) 1.03

Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease:the Dallas Heart Study. JACC Cardiovasc Imaging (2010) 1.02

Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats. Biol Pharm Bull (2007) 1.00

The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation. J Ethnopharmacol (2011) 0.99

Antihypertensive effect of Eucommia ulmoides Oliv. extracts in spontaneously hypertensive rats. J Ethnopharmacol (2010) 0.97

Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats. Biol Pharm Bull (2008) 0.95

Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation. Vascul Pharmacol (2012) 0.94

Autonomic nervous system dysregulation in human hypertension. Am J Cardiol (1991) 0.93

Hypoglycemic effect of Du-zhong (Eucommia ulmoides Oliv.) leaves in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract (2005) 0.92

Current challenges in the clinical management of hypertension. Nat Rev Cardiol (2011) 0.89

Inhibition of dystrophin breakdown and endothelial nitric-oxide synthase uncoupling accounts for cytoprotection by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) in left ventricular hypertrophied Mice. J Pharmacol Exp Ther (2009) 0.89

Opposing actions of extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) in regulating microtubule stabilization during cardiac hypertrophy. J Biol Chem (2010) 0.87

Zangfu zheng (patterns) are associated with clinical manifestations of zang shang (target-organ damage) in arterial hypertension. Chin Med (2011) 0.86

Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice. J Ethnopharmacol (2006) 0.86

Effect of crataegus usage in cardiovascular disease prevention: an evidence-based approach. Evid Based Complement Alternat Med (2013) 0.85

Effects of acidic polysaccharides from gastrodia rhizome on systolic blood pressure and serum lipid concentrations in spontaneously hypertensive rats fed a high-fat diet. Int J Mol Sci (2012) 0.84

Effects of puerarin on expression of cardiac Smad3 and Smad7 mRNA in spontaneously hypertensive rat. J Ethnopharmacol (2011) 0.84

Herbal medicines for cardiovascular diseases. Evid Based Complement Alternat Med (2014) 0.83

Study on the hypoglycemic activities and metabolism of alcohol extract of Alismatis Rhizoma. Fitoterapia (2012) 0.83

Hypolipidemic effects of Alismatis rhizome on lipid profile in mice fed high-fat diet. Saudi Med J (2011) 0.83

Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling. J Ethnopharmacol (2010) 0.83

Selected compounds derived from Moutan Cortex stimulated glucose uptake and glycogen synthesis via AMPK activation in human HepG2 cells. J Ethnopharmacol (2010) 0.83

Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study. J Hum Hypertens (2010) 0.82

Anti-hypertension effects of traditional Chinese medicine ju-ling-tang on renal hypertensive rats. Am J Chin Med (2005) 0.82

Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial. Phytomedicine (2011) 0.82

Left ventricular hypertrophy and renin-angiotensin system blockade. Curr Hypertens Rep (2009) 0.81

Total triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-rats. J Pharm Pharmacol (2008) 0.80

Gastrodia elata Ameliorates High-Fructose Diet-Induced Lipid Metabolism and Endothelial Dysfunction. Evid Based Complement Alternat Med (2014) 0.80

Hypertensive cardiac remodeling effects of lignan extracts from Eucommia ulmoides Oliv. bark--a famous traditional Chinese medicine. Am J Chin Med (2013) 0.79

Dietary fish oil improves endothelial function and lowers blood pressure via suppression of sphingolipid-mediated contractions in spontaneously hypertensive rats. J Hypertens (2014) 0.79

Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients. Evid Based Complement Alternat Med (2014) 0.78

Effect of traditional Chinese medicine Qin-Dan-Jiang-Ya-Tang on remodeled vascular phenotype and osteopontin in spontaneous hypertensive rats. J Ethnopharmacol (2006) 0.77

Association of exercise heart rate response and incidence of hypertension in men. Mayo Clin Proc (2014) 0.77

Ameliorative effect of Eucommia ulmoides Oliv. leaves extract (ELE) on insulin resistance and abnormal perivascular innervation in fructose-drinking rats. J Ethnopharmacol (2010) 0.77

Association of resting heart rate and hypertension stages on all-cause and cardiovascular mortality among elderly Koreans: the Kangwha Cohort Study. J Geriatr Cardiol (2016) 0.76

[Application of kidney-nourishing herbal medicine for treating hypertension]. Zhongguo Zhong Yao Za Zhi (2013) 0.76

Ameliorating effect and potential mechanism of Rehmannia glutinosa oligosaccharides on the impaired glucose metabolism in chronic stress rats fed with high-fat diet. Phytomedicine (2013) 0.76

Is it a new approach for treating senile hypertension with kidney-tonifying chinese herbal formula? A systematic review of randomized controlled trials. Evid Based Complement Alternat Med (2014) 0.76

[Effects of Rehmannia glutinosa oligosaccharides on proliferation of 3T3-L1 adipocytes and insulin resistance]. Zhongguo Zhong Yao Za Zhi (2006) 0.76

Gastrodin Reduces Blood Pressure by Intervening with RAAS and PPARγ in SHRs. Evid Based Complement Alternat Med (2015) 0.76

[Effect of paeonol on blood pressure and blood flow in artery of spontaneously hypertensive rats and its mechanisms related on vasomotion]. Zhongguo Zhong Yao Za Zhi (2015) 0.76